DekaBank Deutsche Girozentrale’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $425K | Hold |
|
|||||
2024
Q4 | $259K | Hold |
|
|||||
2024
Q3 | $455K | Hold |
|
|||||
2024
Q2 | $221K | Hold |
|
|||||
2024
Q1 | $420K | Hold |
|
|||||
2023
Q4 | $761K | Hold |
|
|||||
2023
Q3 | $1.01M | Hold |
|
|||||
2023
Q2 | $2.14M | Hold |
|
|||||
2023
Q1 | $2.66M | Hold |
|
|||||
2022
Q4 | $1.6M | Hold |
|
|||||
2022
Q3 | $2.21M | Hold |
|
|||||
2022
Q2 | $1.22M | Buy |
|
|||||
2022
Q1 | $507K | Sell |
|
|||||
2021
Q4 | $468K | Sell |
|
|||||
2021
Q3 | $1.88M | Hold |
|
|||||
2021
Q2 | $1.97M | Hold |
|
|||||
2021
Q1 | $1.86M | Buy |
|
|||||
2020
Q4 | $1.71M | Buy |
|
|||||
2020
Q3 | $1.16M | Buy |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $550K | Sell |
|
|||||
2019
Q2 | $1.01M | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $847K | Buy |
|
|||||
2016
Q2 | – | Sell |
|
|||||
2016
Q1 | $239K | Sell |
|
|||||
2015
Q4 | $497K | Buy |
|
|||||
2015
Q3 | $357K | Buy |
|
|||||
2015
Q2 | $368K | Buy |
|
|||||
2015
Q1 | $230K | Buy |
|